HCPCS Q2050
Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
HCPCS Information
- HCPCS Code: Q2050
- The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS Q2050 identifies the type of service or supply used while any of the 29 NDC codes below could be used to specify the exact drug used.
- Short Description
- Doxorubicin inj 10mg
- Long Description
- Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
- Pricing Indicator
- Drugs
- Multiple Pricing Indicator
- Not applicable as HCPCS priced under one methodology
- Coverage Description
- Special coverage instructions apply
- BETOS Type of Service
- Chemotherapy
- Medicare Payment Limit
- $109.28
- Medicare Co-Insurance Percentage
- 20.000%
- HCPCS Classification
- List of HCPCS codes for: Temporary Codes (Q-codes)
HCPCS Crossover to NDC Codes
The NDC codes below allow precise billing based on the specific manufacturer and medication used:
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0338-0063 | Doxil | Doxorubicin Hydrochloride | Injection, Suspension, Liposomal | Intravenous | Baxter Healthcare Company | ACTIVE | |
| 0338-0067 | Doxil | Doxorubicin Hydrochloride | Injection, Suspension, Liposomal | Intravitreal | Baxter Healthcare Company | ACTIVE | |
| 0338-0080 | Doxorubicin Hydrochloride Liposome | Doxorubicin Hydrochloride Liposome | Injection, Suspension, Liposomal | Intravenous | Baxter Healthcare Company | ACTIVE | |
| 0338-0086 | Doxorubicin Hydrochloride Liposome | Doxorubicin Hydrochloride Liposome | Injection, Suspension, Liposomal | Intravenous | Baxter Healthcare Company | ACTIVE | |
| 0338-9665 | Doxil | Doxorubicin Hydrochloride | Injection, Suspension, Liposomal | Intravenous | Baxter Healthcare Corporation | ACTIVE | |
| 0338-9667 | Doxil | Doxorubicin Hydrochloride | Injection, Suspension, Liposomal | Intravenous | Baxter Healthcare Corporation | ACTIVE | |
| 0574-0930 | Doxorubicin Hydrochloride | Padagis Us Llc | |||||
| 0574-0931 | Doxorubicin Hydrochloride | Padagis Us Llc | |||||
| 16714-742 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Northstar Rxllc | ACTIVE | |
| 16714-856 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Northstar Rxllc | ACTIVE | |
| 43598-283 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Dr. Reddy's Laboratories Inc | ACTIVE | |
| 43598-541 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Dr. Reddy's Laboratories Inc | ACTIVE | |
| 43598-682 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Dr. Reddy's Laboratories Inc | ACTIVE | |
| 43598-683 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Dr. Reddy's Laboratories Inc | ACTIVE | |
| 47335-049 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Sun Pharmaceutical Industries, Inc. | ACTIVE | |
| 47335-050 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Sun Pharmaceutical Industries, Inc. | ACTIVE | |
| 59676-966 | Doxorubicin Hydrochloride Liposome | Janssen Products, Lp | |||||
| 68001-345 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Bluepoint Laboratories | ACTIVE | |
| 68001-492 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Bluepoint Laboratories | ACTIVE | |
| 68001-493 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Bluepoint Laboratories | ACTIVE | |
| 68001-629 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injection, Suspension, Liposomal | Intravenous | Bluepoint Laboratories | ACTIVE | |
| 70710-1530 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Zydus Pharmaceuticals Usa Inc. | ACTIVE | |
| 70710-1531 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Zydus Pharmaceuticals Usa Inc. | ACTIVE | |
| 70748-339 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injection, Suspension, Liposomal | Intravenous | Lupin Pharmaceuticals, Inc. | ACTIVE | |
| 70748-340 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injection, Suspension, Liposomal | Intravenous | Lupin Pharmaceuticals, Inc. | ACTIVE | |
| 72603-103 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Northstar Rxllc | ACTIVE | |
| 72603-200 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | Injectable, Liposomal | Intravenous | Northstar Rxllc | ACTIVE | |
| 72603-346 | Doxorubicin Hydrochloride | Northstar Rxllc | |||||
| 72603-507 | Doxorubicin Hydrochloride | Northstar Rxllc |
